View in EDS

Novel insulin sensitizer MSDC-0602K improves insulinemia and fatty liver disease in mice, alone and in combination with liraglutide.

Saved in:
Bibliographic Details
Title: Novel insulin sensitizer MSDC-0602K improves insulinemia and fatty liver disease in mice, alone and in combination with liraglutide.
Authors: Kamm DR; Biochemistry & Molecular Biology, Saint Louis University School of Medicine, St Louis, Missouri, USA., Pyles KD; Biochemistry & Molecular Biology, Saint Louis University School of Medicine, St Louis, Missouri, USA., Sharpe MC; Biochemistry & Molecular Biology, Saint Louis University School of Medicine, St Louis, Missouri, USA., Healy LN; LNH Tox Path Consulting LLC, Newbury Park, California, USA., Colca JR; Cirius Therapeutics, Kalamazoo, Michigan, USA; Cirius Therapeutics, San Diego, California, USA., McCommis KS; Biochemistry & Molecular Biology, Saint Louis University School of Medicine, St Louis, Missouri, USA. Electronic address: kyle.mccommis@health.slu.edu.
Source: The Journal of biological chemistry [J Biol Chem] 2021 Jan-Jun; Vol. 296, pp. 100807. Date of Electronic Publication: 2021 May 20.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Inc. on behalf of American Society for Biochemistry and Molecular Biology Country of Publication: United States NLM ID: 2985121R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1083-351X (Electronic) Linking ISSN: 00219258 NLM ISO Abbreviation: J Biol Chem Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 34022222
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Novel insulin sensitizer MSDC-0602K improves insulinemia and fatty liver disease in mice, alone and in combination with liraglutide.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Kamm+DR%22">Kamm DR</searchLink>; Biochemistry & Molecular Biology, Saint Louis University School of Medicine, St Louis, Missouri, USA.<br /><searchLink fieldCode="AU" term="%22Pyles+KD%22">Pyles KD</searchLink>; Biochemistry & Molecular Biology, Saint Louis University School of Medicine, St Louis, Missouri, USA.<br /><searchLink fieldCode="AU" term="%22Sharpe+MC%22">Sharpe MC</searchLink>; Biochemistry & Molecular Biology, Saint Louis University School of Medicine, St Louis, Missouri, USA.<br /><searchLink fieldCode="AU" term="%22Healy+LN%22">Healy LN</searchLink>; LNH Tox Path Consulting LLC, Newbury Park, California, USA.<br /><searchLink fieldCode="AU" term="%22Colca+JR%22">Colca JR</searchLink>; Cirius Therapeutics, Kalamazoo, Michigan, USA; Cirius Therapeutics, San Diego, California, USA.<br /><searchLink fieldCode="AU" term="%22McCommis+KS%22">McCommis KS</searchLink>; Biochemistry & Molecular Biology, Saint Louis University School of Medicine, St Louis, Missouri, USA. Electronic address: kyle.mccommis@health.slu.edu.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%222985121R%22">The Journal of biological chemistry</searchLink> [J Biol Chem] 2021 Jan-Jun; Vol. 296, pp. 100807. <i>Date of Electronic Publication: </i>2021 May 20.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Inc%2E+on+behalf+of+American+Society+for+Biochemistry+and+Molecular+Biology%22">Elsevier Inc. on behalf of American Society for Biochemistry and Molecular Biology </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>2985121R <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1083-351X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200219258%22">00219258 </searchLink><i>NLM ISO Abbreviation: </i>J Biol Chem <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34022222
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.jbc.2021.100807
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 100807
    Titles:
      – TitleFull: Novel insulin sensitizer MSDC-0602K improves insulinemia and fatty liver disease in mice, alone and in combination with liraglutide.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Kamm DR
      – PersonEntity:
          Name:
            NameFull: Pyles KD
      – PersonEntity:
          Name:
            NameFull: Sharpe MC
      – PersonEntity:
          Name:
            NameFull: Healy LN
      – PersonEntity:
          Name:
            NameFull: Colca JR
      – PersonEntity:
          Name:
            NameFull: McCommis KS
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Text: 2021 Jan-Jun
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-electronic
              Value: 1083-351X
          Numbering:
            – Type: volume
              Value: 296
          Titles:
            – TitleFull: The Journal of biological chemistry
              Type: main
ResultId 1